Absorbable Heart Stent Market Research Report - Global Forecast till 2027

Global Absorbable Heart Stent Market Research Report: Information by Material (Metal and Polymer), Application (Coronary Artery Disease and Periphery Artery Disease), End-Use (Hospitals and Clinics, Cardiovascular Centers, Research Institutes and Organizations and Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/MED/0669-HCR | February 2021 | Region: Global | 80 pages

Please note that the assessment period of report has been updated from 2019-2025 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


Absorbable Heart Stent Market is expected to register 11.8% CAGR during the forecast period of 2019 to 2025 and will achieve USD 428.4 Million in 2025. The market was valued at USD 264.6 million in 2018.


Stents are small expandable tubes that are used to inflate the arteries of the patient to prevent blockage. These are called heart stents or cardiac stents. Stents are inserted into the artery of a patient suffering from coronary disease due to the build-up of plaque. It is used for widening the narrowed arteries and aids in reducing chest pain and limiting chances of heart attack. These stents are widely used for the treatment of coronary and peripheral artery diseases.


Segmentation


The global absorbable heart stent has been segmented based on material, application, and end-use. The global market, based on material, has been divided into metal and polymer. The polymer segment is expected to be the largest segment owing to the increasing applications and use of polymer-based stents.


The global market, based on application, has been bifurcated into coronary artery disease and periphery artery disease. The coronary artery disease segment is the largest in terms of value due to prevalence of coronary diseases in geriatric individuals and is predicted to achieve more revenue in the upcoming absorbable heart stent market.       


The global market, based on end use, has been segmented into hospitals & clinics, cardiovascular centers, research institutes and organizations, and others. Hospitals & clinics are the largest end users of absorbable heart stents. The segment is anticipated to hold a major share of the market during the forecast period. This is due to the increasing number heart surgeries and the growing risk of coronary artery disease (CAD) and peripheral artery disease (PAD).


The market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The absorbable heart stent in the Americas has further been divided into North America and Latin America. In North America, the market is bifurcated into the US and Canada. The European absorbable heart stent has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, Italy, Spain, the UK, and the rest of Western Europe. The absorbable heart stent in Asia-Pacific has been segmented into Japan, China, India, South Korea, and Australia. The absorbable heart stent in the Middle East & Africa has been divided into the Middle East and Africa.


Key Players


The key players in global absorbable heart stent are Abbott Laboratories, Biotronik, REVA Medical, Inc., Elixir Medical Corporation, B. Braun Melsungen AG, KYOTO MEDICAL PLANNING Co., Ltd., Boston Scientific Corporation, Medtronic, Terumo Medical Corporation, and Meril Life Sciences Pvt. Ltd.        


Regional Market Summary


Global Absorbable Heart Stent Share (%), by Region, 2018  Absorbable Heart Stent Market


Source: World Health Organization (WHO), Institute of Medicine (IOM)


The market in the Americas is projected to have a steady growth rate during the forecast period owing to the increasing number of patients with chronic diseases and government initiatives for healthcare reforms. Moreover, there is an increase in the use of these stents by healthcare physicians. A patient’s preference for minimally invasive therapies is driving the growth of the absorbable heart stent market in this region.


The market in Europe showed substantial growth during the forecast period. The market growth in this region can be attributed due to the huge patient pool and prevalence of CAD and PAD. According to latest data from Centers for Disease Control and Prevention 11.3 million cardiovascular surgeries were carried out in this region in 2018.


The market in Asia-Pacific is expected to dominate the global absorbable heart stent due to the increase in development of healthcare infrastructures. Moreover, there is an increase in number of patients suffering from chronic disease, including cardiovascular disease. For instance, according to World Heart Federation, cardiovascular disease is estimated to account for 87% of total adult deaths in China in 2016.


The market in the Middle East & Africa is expected to grow at a substantial rate due to the increase in the use of surgical treatment for cardiovascular diseases in the region.


Global Absorbable Heart Stent Market, by Material



  • Metal

  • Polymer


Global Absorbable Heart Stent Market by Application



  • Coronary Artery Disease

  • Peripheral Artery Disease


Global Absorbable Heart Stent Market, by End-Use



  • Hospital & Clinics

  • Research and Academic Institutes

  • Others


Global Absorbable Heart Stent Market, by Region



  • Americas

    • North America

    • US

    • Canada





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific 





  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Medical device companies

  • Research and development (R&D) companies

  • Government research institutes

  • Academic institutes and universities

  • Venture capitalists



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 428.4 Million
  CAGR   11.8% CAGR
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Material, Application and End-Use
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Laboratories, Biotronik, REVA Medical, Inc., Elixir Medical Corporation, B. Braun Melsungen AG, KYOTO MEDICAL PLANNING Co., Ltd., Boston Scientific Corporation, Medtronic, Terumo Medical Corporation, and Meril Life Sciences Pvt. Ltd
  Key Market Opportunities   Demand for absorbable heart stents is increasing due to advancement in technology of developing heart stents and increase in number of cardiac surgeries.
  Key Market Drivers

  • Increase in number of patients suffering from chronic disease, including cardiovascular disease.
  • Increasing unhealthy habits, lack of physical exercise and increasing prevalence of cardiac diseases contributed growth to the market.


  • TABLE OF CONTENTS


    REPORT PROLOGUE

    MARKET INTRODUCTION


    2.1. Definition

    2.2. Scope of the Study

    2.2.1. Research Objective

    2.2.2. Assumptions

    2.2.3. Limitations


    RESEARCH METHODOLOGY


    3.1. Overview

    3.2. Primary Research

    3.3. Secondary Research

    3.4. Market Size Estimation


    MARKET DYNAMICS


    4.1. Overview

    4.2. Drivers

    4.3. Restraints

    4.4. Opportunities


    MARKET FACTOR ANALYSIS


    5.1. Porter’s Five Forces Analysis

    5.1.1. Bargaining Power of Suppliers

    5.1.2. Bargaining Power of Buyers

    5.1.3. Threat of New Entrants

    5.1.4. Threat of Substitutes

    5.1.5. Intensity of Rivalry

    5.2. Value Chain Analysis



    GLOBAL ABSORBABLE HEART STENT MARKET, BY MATERIAL


    6.1. Overview

    6.2. Metal

    Market Estimates & Forecast, by Region, 2019–2025

    Market Estimates & Forecast, by Country, 2019–2025

    6.3. Polymer

    Market Estimates & Forecast, by Region, 2019–2025

    Market Estimates & Forecast, by Country, 2019–2025


    GLOBAL ABSORBABLE HEART STENT MARKET, BY APPLICATION


    7.1. Overview

    7.2. Coronary Artery Disease

    Market Estimates & Forecast, by Region, 2019–2025

    Market Estimates & Forecast, by Country, 2019–2025

    7.3. Periphery Artery Disease

    Market Estimates & Forecast, by Region, 2019–2025

    Market Estimates & Forecast, by Country, 2019–2025



    GLOBAL ABSORBABLE HEART STENT MARKET, BY END USE


    8.1. Overview

    8.2. Hospitals & Clinics

    Market Estimates & Forecast, by Region, 2019–2025

    Market Estimates & Forecast, by Country, 2019–2025

    8.3. Research and Academic Institutes

    Market Estimates & Forecast, by Region, 2019–2025

    Market Estimates & Forecast, by Country, 2019–2025

    8.4. Others

    Market Estimates & Forecast, by Region, 2019–2025

    Market Estimates & Forecast, by Country, 2019–2025


    GLOBAL ABSORBABLE HEART STENT MARKET, BY REGION


    9.1. Overview

    9.2. Americas

    9.2.1. North America

    9.2.1.1. US

    9.2.1.2. Canada

    9.2.2. Latin America

    9.3. Europe

    9.3.1. Western Europe

    9.3.1.1. Germany

    9.3.1.2. France

    9.3.1.3. Italy

    9.3.1.4. Spain

    9.3.1.5. UK

    9.3.1.6. Rest of Western Europe

    9.3.2. Eastern Europe

    9.4. Asia-Pacific

    9.4.1. Japan

    9.4.2. China

    9.4.3. India

    9.4.4. Australia

    9.4.5. South Korea

    9.4.6. Rest of Asia-Pacific

    9.5. Middle East & Africa

    9.5.1. Middle East

    9.5.2. Africa


    COMPANY LANDSCAPE


    10.1. Overview

    10.2. Competitive Analysis

    10.3. Market Share Analysis

    10.4. Major Growth Strategy in the Global Absorbable Heart Stent Market

    10.5. Competitive Benchmarking

    10.6. Leading Players in Terms of Number of Developments in the Global Absorbable Heart Stent Market

    10.7. Key developments and Growth Strategies

    10.7.1. Product Launch/Service Deployment

    10.7.2. Mergers and Acquisitions

    10.7.3. Joint Ventures

    10.8. Major Players Financial Matrix & Market Ratio

    10.8.1. Sales & Operating Income 2020

    10.8.2. Major Players R&D Expenditure 2020

    10.9. Major Players Capital Market Ratio


    COMPANY PROFILES


    11.1. Abbott Laboratories

    11.1.1. Company Overview

    11.1.2. Product Overview

    11.1.3. Financial Overview

    11.1.4. Key Developments

    11.1.5. SWOT Analysis

    11.1.6. Key Strategies

    11.2. Biotronik

    11.2.1. Company Overview

    11.2.2. Product Overview

    11.2.3. Financial Overview

    11.2.4. Key Developments

    11.2.5. SWOT Analysis

    11.2.6. Key Strategies

    11.3. REVA Medical, Inc.

    11.3.1. Company Overview

    11.3.2. Product Overview

    11.3.3. Financial Overview

    11.3.4. Key Developments

    11.3.5. SWOT Analysis

    11.3.6. Key Strategies

    11.4. Elixir Medical Corporation

    11.4.1. Company Overview

    11.4.2. Product Overview

    11.4.3. Financial Overview

    11.4.4. Key Developments

    11.4.5. SWOT Analysis

    11.4.6. Key Strategies

    11.5. Medtronic

    11.5.1. Company Overview

    11.5.2. Product Overview

    11.5.3. Financial Overview

    11.5.4. Key Developments

    11.5.5. SWOT Analysis

    11.5.6. Key Strategies

    11.6. KYOTO MEDICAL PLANNING Co., Ltd.

    11.6.1. Company Overview

    11.6.2. Product Overview

    11.6.3. Financial Overview

    11.6.4. Key Developments

    11.6.5. SWOT Analysis

    11.6.6. Key Strategies

    11.7. Boston Scientific Corporation

    11.7.1. Company Overview

    11.7.2. Product Overview

    11.7.3. Financial Overview

    11.7.4. Key Developments

    11.7.5. SWOT Analysis

    11.7.6. Key Strategies

    11.8. Terumo Medical Corporation

    11.8.1. Company Overview

    11.8.2. Product Overview

    11.8.3. Financial Overview

    11.8.4. Key Developments

    11.8.5. SWOT Analysis

    11.8.6. Key Strategies

    11.9. Meril Life Sciences Pvt. Ltd

    11.9.1. Company Overview

    11.9.2. Product Overview

    11.9.3. Financial Overview

    11.9.4. Key Developments

    11.9.5. SWOT Analysis

    11.9.6. Key Strategies

    11.10. B. Braun Melsungen AG

    11.10.1. Company Overview

    11.10.2. Product Overview

    11.10.3. Financial Overview

    11.10.4. Key Developments

    11.10.5. SWOT Analysis

    11.10.6. Key Strategies

    11.11. Others


    APPENDIX


    12.1. References

    12.2. Related Reports


    LIST OF TABLES

    TABLE 1 GLOBAL ABSORBABLE HEART STENT MARKET SYNOPSIS, 2019–2025

    TABLE 2 GLOBAL ABSORBABLE HEART STENT MARKET ESTIMATES & FORECAST, 2020-2027(USD MILLION)

    TABLE 3 GLOBAL ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)

    TABLE 4 GLOBAL ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)

    TABLE 5 GLOBAL ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)

    TABLE 6 GLOBAL ABSORBABLE HEART STENT MARKET, BY REGION, 2020-2027(USD MILLION)

    TABLE 7 NORTH AMERICA: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)

    TABLE 8 NORTH AMERICA: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)

    TABLE 9 NORTH AMERICA: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)

    TABLE 10 US: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)

    TABLE 11 US: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)

    TABLE 12 US: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)

    TABLE 13 CANADA: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)

    TABLE 14 CANADA: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)

    TABLE 15 CANADA: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)

    TABLE 16 LATIN AMERICA: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)

    TABLE 17 LATIN AMERICA: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)

    TABLE 18 LATIN AMERICA: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)

    TABLE 19 EUROPE: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)

    TABLE 20 EUROPE: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)

    TABLE 21 EUROPE: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)

    TABLE 22 WESTERN EUROPE: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)

    TABLE 23 WESTERN EUROPE: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)

    TABLE 24 WESTERN EUROPE: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)

    TABLE 25 EASTERN EUROPE: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)

    TABLE 26 EASTERN EUROPE: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)

    TABLE 27 EASTERN EUROPE: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)

    TABLE 28 ASIA-PACIFIC: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)

    TABLE 29 ASIA-PACIFIC: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)

    TABLE 30 ASIA-PACIFIC: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)

    TABLE 31 MIDDLE EAST & AFRICA: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)

    TABLE 32 MIDDLE EAST & AFRICA: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)

    TABLE 33 MIDDLE EAST & AFRICA: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)


    LIST OF FIGURES

    FIGURE 1 RESEARCH PROCESS

    FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ABSORBABLE HEART STENT MARKET

    FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ABSORBABLE HEART STENT MARKET

    FIGURE 4 GLOBAL ABSORBABLE HEART STENT MARKET SHARE, BY MATERIAL, 2020 (%)

    FIGURE 5 GLOBAL ABSORBABLE HEART STENT MARKET SHARE, BY APPLICATION, 2020 (%)

    FIGURE 6 GLOBAL ABSORBABLE HEART STENT MARKET SHARE, BY END USE, 2020 (%)

    FIGURE 7 GLOBAL ABSORBABLE HEART STENT MARKET SHARE, BY REGION, 2020 (%)

    FIGURE 8 AMERICAS: ABSORBABLE HEART STENT MARKET SHARE BY REGION, 2020 (%)

    FIGURE 9 NORTH AMERICA: ABSORBABLE HEART STENT MARKET SHARE, BY COUNTRY, 2020 (%)

    FIGURE 10 EUROPE: ABSORBABLE HEART STENT MARKET SHARE, BY REGION, 2020 (%)

    FIGURE 11 WESTERN EUROPE: ABSORBABLE HEART STENT MARKET SHARE, BY COUNTRY, 2020 (%)

    FIGURE 12 ASIA-PACIFIC: ABSORBABLE HEART STENT MARKET SHARE, BY COUNTRY, 2020 (%)

    FIGURE 13 MIDDLE EAST & AFRICA: ABSORBABLE HEART STENT MARKET SHARE, BY COUNTRY, 2020 (%)

    FIGURE 14 GLOBAL ABSORBABLE HEART STENT MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

    FIGURE 15 ABBOTT LABORATORIES.: KEY FINANCIALS

    FIGURE 16 ABBOTT LABORATORIES: SEGMENTAL REVENUE

    FIGURE 17 ABBOTT LABORATORIES: REGIONAL REVENUE

    FIGURE 18 BIOTRONIK: KEY FINANCIALS

    FIGURE 19 BIOTRONIK: SEGMENTAL REVENUE

    FIGURE 20 BIOTRONIK: REGIONAL REVENUE

    FIGURE 21 REVA MEDICAL, INC.: KEY FINANCIALS

    FIGURE 22 REVA MEDICAL, INC.: SEGMENTAL REVENUE

    FIGURE 23 REVA MEDICAL, INC.: REGIONAL REVENUE

    FIGURE 24 ELIXIR MEDICAL CORPORATION: KEY FINANCIALS

    FIGURE 25 ELIXIR MEDICAL CORPORATION: SEGMENTAL REVENUE

    FIGURE 26 ELIXIR MEDICAL CORPORATION: REGIONAL REVENUE

    FIGURE 27 MEDTRONIC: KEY FINANCIALS

    FIGURE 28 MEDTRONIC: SEGMENTAL REVENUE

    FIGURE 29 MEDTRONIC: REGIONAL REVENUE

    FIGURE 30 KYOTO MEDICAL PLANNING CO., LTD: KEY FINANCIALS

    FIGURE 31 KYOTO MEDICAL PLANNING CO., LTD: SEGMENTAL REVENUE

    FIGURE 32 KYOTO MEDICAL PLANNING CO., LTD: REGIONAL REVENUE

    FIGURE 33 BOSTON SCIENTIFIC CORPORATION: KEY FINANCIALS

    FIGURE 34 BOSTON SCIENTIFIC CORPORATION: SEGMENTAL REVENUE

    FIGURE 35 BOSTON SCIENTIFIC CORPORATION: REGIONAL REVENUE

    FIGURE 36 TERUMO MEDICAL CORPORATION: KEY FINANCIALS

    FIGURE 37 TERUMO MEDICAL CORPORATION: SEGMENTAL REVENUE

    FIGURE 38 TERUMO MEDICAL CORPORATION: REGIONAL REVENUE

    FIGURE 39 MERIL LIFE SCIENCES PVT. LTD: KEY FINANCIALS

    FIGURE 40 MERIL LIFE SCIENCES PVT. LTD: SEGMENTAL REVENUE

    FIGURE 41 MERIL LIFE SCIENCES PVT. LTD: REGIONAL REVENUE

    FIGURE 42 B. BRAUN MELSUNGEN AG: KEY FINANCIALS

    FIGURE 43 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE

    FIGURE 44 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE